Video Topic: Progress & Promise in Stem Cell Research

Diabetes: Progress and Promise in Stem Cell Research

CIRM has funded the Diabetes Disease Team led by scientists at ViaCyte, Inc., UCSF, and the La Jolla Institute for Allergy and Immunology. This team aims to bring an embryonic stem cell based therapy for diabetes to clinical trials. For more info, see our diabetes fact sheet.

Cures through Collaboration: Funding a Team Approach to Disease Research

Both the Guthy-Jackson Charitable Foundation (GJCF) and the California Institute for Regenerative Medicine (CIRM) share a similar vision for funding a team approach to disease research. When Victoria Jackson’s daughter, Ali, was diagnosed with NMO – a rare incurable disease that can lead to blindness, paralysis and even death – Jackson created the GJCF and […]

Lou Gehrig’s Disease (ALS): Progress and Promise in Stem Cell Research

CIRM has funded the ALS Disease Team led by scientists at who aim to bring a human embryonic stem cell based ALS therapy to clinical trials within four years. Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease, is a progressive motor neuron disorder. Most people with ALS die within 3 to 5 years […]

Progress and Promise in Spinal Cord Injury

The world’s first human embryonic stem cell-based clinical trial has been approved for the treatment of spinal cord injury. Oswald Steward, Director of the Reeve-Irvine Research Center at UC Irvine and member of the CIRM Governing Board, discusses the pioneering work that led to the clinical trial and Roman Reed gives a personal perspective of […]

Progress and Promise in HIV/AIDS

CIRM has funded two HIV/AIDS Disease Teams led by scientists at UCLA and the City of Hope who are focused on stem cell transplant strategies that promise a long lasting resistance to HIV. Antiretroviral therapy provides life-saving medicine to HIV-infected people but it is not a cure. Long-term exposure to the drugs and the virus […]

Huntington’s Disease: Progress and Promise in Stem Cell Research

Huntington’s disease is an inherited neurodegenerative disorder that typically strikes in a person’s thirties and leads to death about 10 to 15 years later. No effective therapy exists for the disease. Jan Nolta, director of the UC Davis Stem Cell Program and Institute for Regenerative Cures, has a CIRM Early Translational Award to develop stem […]

Progress and Promise in Macular Degeneration

Macular degeneration is a disease associated with aging that gradually destroys sharp central vision, making it impossible to see faces, to read, or to drive. No therapy exists for the most common, or “dry”, form of the disease. Mark Humayun, professor of ophthalmology & biomedical engineering at the Doheny Eye Institute, University of Southern California, […]

Progress and Promise in Parkinson’s

Parkinson’s disease is a neurodegenerative disease that affects nearly a million people in the United States. The symptoms include tremors, slow movement, muscle rigidity and less facial expression. No cure exists for the disease and current medications become less effective over time. Learn more about Parkinson’s disease and see a list of all CIRM Parkinson’s […]

Progress and Promise in Leukemia

Myeloid proliferative diseases are life threatening blood disorders that can lead to acute leukemia. Using stem cells, the laboratory of Dr. Catriona Jamieson showed that a specific small molecule could halt these diseases. This work, funded in part by the California Institute for Regenerative Medicine, led to a clinical trial, which is now underway. In […]